1Y Close · As of Aug 26, 2026
Pharmsville operates in the Food Products sector.
Legal name: Pharmsville Co., Ltd.
In fiscal year 2025, Pharmsville (318010) reported revenue of 12.7 billion KRW, down 23.9% from 16.7 billion KRW a year earlier.
Operating profit was -673 million KRW and net income was 2.9 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 29.5 billion KRW, with a P/B of 0.44.
These figures can be verified in the DART filing (receipt no. 20260318001701).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 12.7B | -673M | 2.9B |
| 2024 | 16.7B | -258M | 1.6B |
| 2023 | 21.4B | 1.6B | 3.3B |
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-13 | Semi-Annual Report (2026.06) |